US FDA Current Affairs, GK & News

US FDA  Current Affairs, GK & News

GoI regulates 24 classes of medical devices as drugs

On April 1, 2020, the National Pharmaceutical Pricing Authority revised the ceiling price of 883 scheduled formulations. The authority also informed that the disruption of supply of Active Pharmaceutical Ingredients are returning to normalcy. Highlights The NPPA has notified 24 classes of medical devices as drugs under Drugs and Cosmetics Act, 1940. The prices of ..

Month: 

Category: 

Topics: 

FDA approves Convalescent Plasma Treatment for seriously ill COVID-19 patients

The Food and Drug Administration of the United States has approved the use of Convalescent plasma collected from patients recovered from COVID-19 to treat seriously ill COVID-19 patients. The idea of the method is to inject plasma with antibodies into critically ill patients for them to gain immunity against the virus. Highlights The Convalescent plasma ..

Month: 

Category: 

Topics: 

PRETOMANID: US FDA approves new drug for drug-resistant TB

United States (US) Food and Drug Administration (FDA) has approved new drug-Pretomanid for treating drug-resistant strain of Tuberculosis (TB). Pretomanid is novel compound developed by New York-based non-profit organisation TB Alliance. It is used alongside two other antibiotics (bedaquiline and linezolid) to treat extremely drug-resistant strain of tuberculosis. This three-drug regimen is collectively known as ..

Month: 

Category: 

Topics: 

US approves first test to screen Zika virus in donated blood

United States Food and Drug Administration (FDA) has approved ‘Cbas Zika test’ for detecting Zika virus in donated blood. It is first of kind test approved by FDA for detecting Zika virus in donated blood. The cobas Zika test is manufactured by Roche Molecular Systems Inc. It is intended for use by blood collection establishments ..

Month: 

Topics: